Skip to content

Investigation of multimodality treatment for unresectable or recurrent gastric cancer

Investigation of multimodality treatment for unresectable or recurrent gastric cancer - Investigation of multimodality treatment for unresectable or recurrent gastric cancer

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019544
Enrollment
250
Registered
2015-11-01
Start date
2015-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable or recurrent gastric cancer

Interventions

None listed

Sponsors

Kobe University Graduate School of Medicine, Division of Gastrointestinal Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: unresectable or recurrent gastric cancer

Exclusion criteria

Exclusion criteria: Patients with other malignant tumor with poorer survival. Patients who decline the offer to use the data.

Design outcomes

Primary

MeasureTime frame
Survival

Secondary

MeasureTime frame
Side effects of chemotherapy, perioperative complication

Countries

Japan

Contacts

Public ContactSatoshi Suzuki

Kobe University Division of Gastrointestinal Surgery

ss147@med.kobe-u.ac.jp078-382-5925

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026